Insights
Access our latest insights & resources
Research Type: Policy & Legal
Advisory Committee’s Split Decision on Biogen’s Tofersen
Policy & Legal, Research
We expect the FDA to grant accelerated approval of Biogen's (BIIB) ALS treatment...
Read more
Mitigation Expectations for Medicare Advantage Rate Notice
Policy & Legal, Research
Size of Medicare Advantage mitigation may be less than earlier expectations...
Read more
In the TikTok Kerfuffle, Politics Will Win Out over National Security
Policy & Legal, Research
Policy to win out over national security concerns in TikTok debate...
Read more
Hydrogen Update: Will Treasury Exclude Existing Nukes & Renewables?
Policy & Legal, Research
We believe 2023 will be a foundational year for clean hydrogen development in the U.S., with two important federal issues on the horizon...
Read more
Glaukos (GKOS): Pipeline Policy Pathway
Policy & Legal, Research
Following Glaukos’ (GKOS) earnings report, attention now turns to the regulatory...
Read more
Axonics (AXNX): Competition Coding Questions
Policy & Legal, Research
AXNX competitive pressures manageable following AMA disclosure...
Read more
Gas Utilities: The Pilot Light is Beginning to Flicker
Policy & Legal, Research
Gas utilities are facing increasing challenges to their rate base growth due to a host of policy factors...
Read more
States and Utilities Helping Each Other Out
Policy & Legal, Research
Likely winners from Minnesota’s new law adopting a 100% clean energy mandate by 2040...
Read moreShockwave (SWAV): Volatility Ahead?
Policy & Legal, Research
No more than 50% odds to CMS forestalling an implied facility cut of 25%+ for SWAV's IVL procedures...
Read more
UK’s CMA to Microsoft: “We’re Skeptical, Come Convince Us”
Policy & Legal, Research
Path forward emerges for MSFT proposed acquisition of ATVI...
Read more